EQUITY COMPENSATION PLAN - Narrative (Details)	3 Months Ended
	Mar. 31, 2025 USD ($) shares	Mar. 31, 2024 USD ($) shares	Dec. 31, 2024 shares	May 30, 2024 right $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of stock options exercised		$ 25,500,000
Total fair value of stock options	$ 300,000	8,300,000
Merger consideration exercise price (in dollars per share) | $ / shares				$ 35.00
Sale of stock, per share in cash (in dollars per share) | $ / shares				30.00
Sale of stock, price per share, contingency (in dollars per share) | $ / shares				5.00
Cancelled, threshold exercise price (in dollars per share) | $ / shares				$ 35.00
Stock-based compensation expense	$ 2,450,000	$ 6,397,000
Sale of stock, right per share, contingency | right				1
2017 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by Share-based payment award, options, outstanding, number (in shares) | shares				0
Granted (in shares) | shares	0	0
Stock-based compensation expense	$ 0
Unrecognized stock-based compensation expense	$ 0
2024 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by Share-based payment award, options, outstanding, number (in shares) | shares	3,422,000		3,660,000
Granted (in shares) | shares	21,000
Unrecognized stock-based compensation expense	$ 30,900,000
Number of shares authorized (in shares) | shares	4,000,000.0
Total stock-based compensation expense	$ 2,450,000	$ 0
Number of shares authorized, currently available (in shares) | shares	600,000
Stock options exercised (in shares) | shares	0	0
Weighted-average period of recognition (in years)	3 years 2 months 12 days
Options to purchase common stock issued and outstanding | 2017 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	4 years
Contractual term (in years)	10 years
Total stock-based compensation expense		$ 6,397,000
Options to purchase common stock issued and outstanding | 2017 Plan | Cliff Vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	1 year
Options to purchase common stock issued and outstanding | 2024 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual term (in years)	10 years
Options to purchase common stock issued and outstanding | 2024 Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	4 years
Options to purchase common stock issued and outstanding | 2024 Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	1 year